Evaluation of HER2 immunohistochemistry expression in non-standard solid tumors from a Single-Institution Prospective Cohort

• Päätekijät: Saurav Verma (Tekijä), Amanda Chapman (Tekijä), Lee-Anne Pickard (Tekijä), Danielle Porplycia (Tekijä), Haley McConkey (Tekijä), Patricia Jarosz (Tekijä), James Sinfield (Tekijä), Carolyn Lauzon-Young (Tekijä), Matthew J Cecchini (Tekijä), Christopher Howlett (Tekijä), Natalie Grindrod (Tekijä), Bekim Sadikovic (Tekijä), Stephen A Welch (Tekijä), Daniel Breadner (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Open Exploration Publishing Inc., 2024-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Aim: Human epidermal growth factor receptor-2 (HER2) is a well-established prognostic and predictive biomarker. It is an FDA-approved therapeutic target for HER2 positive breast, gastroesophageal, and more recently, lung and colon cancers. It is an emerging biomarker in biliary tract, bladder, cervi...